Use of antibiotics and risk of psychiatric disorders in newly diagnosed cancer patients: a population-based cohort study in SwedenShow others and affiliations
2022 (English)In: Cancer Epidemiology, Biomarkers and Prevention, ISSN 1055-9965, E-ISSN 1538-7755, Vol. 31, no 3, p. 528-535Article in journal (Refereed) Published
Abstract [en]
BACKGROUND: Antibiotic-induced dysbiosis is associated with an increased risk of depression and anxiety in the general populations. A diagnosis of cancer is associated with an immediately and dramatically elevated risk of psychiatric disorders, but the potential influence of pre-diagnostic antibiotic-induced dysbiosis is unknown.
METHODS: Based on a national cohort of cancer patients in Sweden, we included 309,419 patients who were diagnosed with a first primary malignancy between July 2006 and December 2013. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of first-onset psychosis, depression, anxiety, or stress-related disorders during the first year after cancer diagnosis for antibiotic use during the year before cancer diagnosis.
RESULTS: Compared with no antibiotic use, use of antibiotics was associated with a higher rate of the aforementioned psychiatric disorders (HR, 1.23; 95% CI, 1.16-1.30) after adjustment for sociodemographic factors, comorbidity, potential indications for antibiotics, cancer stage and type. The magnitude of the association was higher for broad-spectrum antibiotics (HR, 1.27; 95% CI, 1.18-1.37), higher doses (HR, 1.33; 95% CI, 1.22-1.44), more frequent (HR, 1.33; 95% CI, 1.21-1.46) and recent use (HR, 1.26; 95% CI, 1.17-1.35).
CONCLUSIONS: Use of antibiotics, especially of broad-spectrum type, of high dose and frequency, with recent use, was associated with an aggravated risk of psychiatric disorders, compared with no antibiotic use.
IMPACT: A better understanding of the microbiota-gut-brain axis may open up a wide avenue for the prevention and treatment of psychiatric disorders in cancer patients.
Place, publisher, year, edition, pages
American Association for Cancer Research , 2022. Vol. 31, no 3, p. 528-535
National Category
Psychiatry
Identifiers
URN: urn:nbn:se:oru:diva-96604DOI: 10.1158/1055-9965.EPI-21-1095ISI: 000767328600001PubMedID: 35027429Scopus ID: 2-s2.0-85125848486OAI: oai:DiVA.org:oru-96604DiVA, id: diva2:1630789
Funder
Swedish Cancer Society, 0846 PjFForte, Swedish Research Council for Health, Working Life and Welfare, 2017-00531The Karolinska Institutet's Research Foundation
Note
Funding agency:
Örebro University (Örebro University Strategic Funds)
2022-01-212022-01-212022-03-29Bibliographically approved